Pharmacogenomics

14 registered clinical trials studyying Pharmacogenomics — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study NCT05764356	Peking University First Hospital	—
Completed	Pharmacogenomics on Individualized Precise Treatment of Patients With Depression NCT05669391	Tongji University	N/A
Unknown	Effect of Genetic Polymorphisms of UGT on the PKs of Indapamide in Egyptians NCT05294484	Ain Shams University	Phase 4
Unknown	Pharmacist-led Interventions to Improve Medication Use NCT05346770	Tabula Rasa HealthCare	—
Unknown	Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting NCT05053815	Tabula Rasa HealthCare	—
Withdrawn	Implementation of a Pharmacist-led Pharmacogenomic Clinical Service NCT04984538	Tabula Rasa HealthCare	—
Unknown	Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Thai Pediatric Surgical Patients NCT03145272	Mahidol University	Phase 4
Unknown	A Pharmacogenomics Study of Simvastatin-Induced Adverse Drug Reaction NCT03261908	Cui Yimin	—
Unknown	A Pharmacogenomics Study of Safety and Efficacy of Enalapril or Enalapril-Folic Acid Therapy in Hypertensive P NCT03259399	Cui Yimin	—
Unknown	Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants NCT03161496	Cui Yimin	—
Unknown	Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor NCT03161002	Cui Yimin	—
Completed	Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice NCT02748148	Tabula Rasa HealthCare	N/A
Completed	A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly NCT03257605	Tabula Rasa HealthCare	—
Unknown	Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile NCT01123538	University Hospital of North Norway	Phase 4